Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2015
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia AG Young, J Mahlangu, R Kulkarni, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2016
Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgeryC Négrier, F Abdul Karim, L M Lepatan, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2015
Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year surveyP F Fogarty, M E Mancuso, R Kasthuri, et al.Journal of Thrombosis and Haemostasis : JTH|February 3, 2015
Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trialP Chowdary, S Lethagen, U Friedrich, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 22, 2016
Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational studyP D James, J Mahlangu, C Bidlingmaier, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 11, 2025
Progress in advanced cellular and gene therapies in South Africa and barriers to patient access: A National Consortium paper on behalf of the BloodSA Cell and Gene Therapy working partyC Hendricks, I Viljoen, M Botes, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 29, 2015
Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia AB Nolan, J Mahlangu, D Perry, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 11, 2022
Prophylaxis is the new standard of care in patients with haemophiliaJ Mahlangu, F Bassa, M Bassingthwaighte, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 26, 2012
Guidelines for the treatment of myelodysplastic syndromes (MDS) in South AfricaV J Louw, F Bassa, S W Chan, et al.Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levelsA D Shapiro, M V Ragni, R Kulkarni, et al.Pageof 2